Synopsis of recent research by authors named "Xinlian Du"
- Xinlian Du's research primarily focuses on the prognostic modeling and immune responses in various cancers, particularly metastatic pancreatic cancer and glioblastoma, using advanced statistical and bioinformatics methods.
- One of Du's key findings includes the development of nomogram models that utilize the systemic immune inflammation index to predict survival rates in patients with metastatic pancreatic cancer undergoing chemotherapy.
- Additionally, Du has identified cuproptosis-related gene DLAT as a potential biomarker in pancreatic adenocarcinoma and developed a prognostic model based on natural killer T cell markers to characterize immune status in glioblastoma patients, enhancing understanding of tumor immunology.
